ArticleFrontiers in oncology2025
Development and validation of a machine learning model to predict the risk of lymph node metastasis in early-stage supraglottic laryngeal cancer.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cervical lymph node metastasis (LNM) is a significant factor that leads to a poor prognosis in laryngeal cancer. Early-stage supraglottic laryngeal cancer (SGLC) is prone to LNM. However, research on risk factors for predicting cervical LNM in early-stage SGLC is limited. This study seeks to create and validate a predictive model through the application of machine learning (ML) algorithms. Methods: The training set and internal validation set data were extracted from the Surveillance, Epidemiology, and End Results (SEER) database. Data from 78 early-stage SGLC patients were collected from Fujian Provincial Hospital for independent external validation. We identified four variables associated with cervical LNM and developed six ML models based on these variables to predict LNM in early-stage SGLC patients. Results: In the two cohorts, 167 (47.44%) and 26 (33.33%) patients experienced LNM, respectively. Age, T stage, grade, and tumor size were identified as independent predictors of LNM. All six ML models performed well, and in both internal and independent external validations, the eXtreme Gradient Boosting (XGB) model outperformed the other models, with AUC values of 0.87 and 0.80, respectively. The decision curve analysis demonstrated that the ML models have excellent clinical applicability. Conclusions: Our study indicates that combining ML algorithms with clinical data can effectively predict LNM in patients diagnosed with early-stage SGLC. This is the first study to apply ML models in predicting LNM in early-stage SGLC patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.